Literature DB >> 4012174

Integration of yaws control and primary health care.

A Meheus.   

Abstract

Where a primary health care (PHC) system (e.g., a community health worker and a health center as the first referral level) is fully operational, control activities for yaws should be part of PHC. Where the whole population is adequately covered, the PHC system is responsible for early detection of cases of active clinical yaws, treatment and follow-up of these cases, treatment and follow-up of contacts, and health education related to yaws control. In circumstances where PHC is not as yet fully implemented, the structure for a yaws control program must be different. In areas with adequately functioning static health services or with a nascent PHC system, yaws control could be started as a vertical program--initial treatment survey and resurvey by a yaws team working in close collaboration with a health worker selected by the community. Subsequently, active yaws surveillance is taken over by that worker who also assumes the other functions of primary health care. In areas with nonexisting or poorly functioning static health services, a program for yaws control should not be implemented because control and effectiveness are likely to be poor.

Mesh:

Year:  1985        PMID: 4012174     DOI: 10.1093/clinids/7-supplement_2.s284

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  3 in total

1.  Yaws eradication: past efforts and future perspectives.

Authors:  Kingsley Asiedu; Bernard Amouzou; Akshay Dhariwal; Marc Karam; Derek Lobo; Sarat Patnaik; André Meheus
Journal:  Bull World Health Organ       Date:  2008-07       Impact factor: 9.408

Review 2.  The Value of Imaging and Composition-Based Biomarkers in Duchenne Muscular Dystrophy Clinical Trials.

Authors:  Stephen M Chrzanowski; Basil T Darras; Seward B Rutkove
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

3.  Yaws in the Western pacific region: a review of the literature.

Authors:  Corinne Capuano; Masayo Ozaki
Journal:  J Trop Med       Date:  2011-12-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.